Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mucic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | PDE4A | P27815 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mucic Acid SCHEMBL5312196 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL15895451 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL5496 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL5497 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL18871641 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL19695496 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL7224759 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL3514596 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL17594183 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 | |
| Mucic Acid SCHEMBL5901 | 1.00 | TSHR (0.69) | TSHRPDE4ACYP2C9TP53ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2961 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | SOLUGEN, INC. (US) | 2026-05-12 | — | — | US | claimed |
| CN-122006711-A | Hydrodeoxygenation catalyst, preparation method and application thereof and preparation method of adipic acid | 中国石油化工股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-3778580-B1 | SYNTHESIS OF FURANS FROM SUGARS VIA KETO INTERMEDIATES | BP CORP NORTH AMERICA INC (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250369123-A1 | ALKOXYIMIDAZOLINIUM QUATERNARY SALT COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS TO INHIBIT CORROSION | ECOLAB USA INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-12486294-B2 | Radioisotope labeled compound for imaging or treatment of prostate cancer | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-12-02 | — | — | US | claimed |
| US-20250354301-A1 | HIGH-TENACITY KERATIN FIBERS | OCEANIT LAB INC (US) | 2025-11-20 | — | — | US | claimed |
| US-20250289990-A1 | COMPOSITIONS AND METHODS FOR IRON CHELATION | SOLUGEN, INC. (US) | 2025-09-18 | — | — | US | claimed |
| US-20250289777-A1 | DEHYDRATION AND CRACKING OF ALPHA-, BETA-DIHYDROXY CARBONYL COMPOUNDS TO LACTIC ACID AND OTHER PRODUCTS | ARCHER DANIELS MIDLAND CO (US) | 2025-09-18 | — | — | US | claimed |
| US-20250269070-A1 | Fluorescent Marker | UCL BUSINESS PLC (GB) | 2025-08-28 | — | — | US | claimed |
| US-12378581-B2 | Compositions and methods for metabolic control of a biofermentation process with synthetic metabolic valves | DUKE UNIVERSITY (US) | 2025-08-05 | — | — | US | claimed |
| EP-0871735-A1 | THERAPEUTIC AND DIAGNOSTIC COMPOSITIONS | Agriculture Victoria Services Pty Ltd (AU) | 1998-10-21 | — | — | EP | claimed |
| US-5654266-A | ISOTONIC AQUEOUS MIXTURE OF SODIUM HYDROXYBUTYRATE, SODIUMPHOSPHATE, SODIUM CITRATE AND CALCIUM CHLORIDE | CHEN OPHTHALMIC LABORATORIES, INC. 13704 KILLARNEY COURT | 1997-08-05 | — | — | US | claimed |
| WO-1997020050-A1 | THERAPEUTIC AND DIAGNOSTIC COMPOSITIONS | DARATECH PTY. LTD. (AU) | 1997-06-05 | — | — | WO | claimed |
| US-5561160-A | ADMINISTERING GLUCARIC ACID OR SALT THEREOF | HANAUSEK, MARGARET | 1996-10-01 | — | — | US | claimed |
| EP-0730862-A1 | Formulation containing glucaric acid for the prevention or treatment of non-cancerous cellular hyperproliferation and dietary supplement | Walaszek, Zbigniew (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0438502-B1 | TECHNETIUM IMAGING AGENTS | CENTOCOR INC (US) | 1995-05-24 | — | — | EP | claimed |
| EP-0528950-A4 | FORMULA AND METHOD FOR THE PREVENTION AND TREATMENT OF HYPERCHOLESTEROLEMIA AND CELLULAR HYPERPROLIFERATIVE DISORDERS | — | 1993-03-24 | — | — | EP | claimed |
| EP-0528950-A1 | FORMULA AND METHOD FOR THE PREVENTION AND TREATMENT OF HYPERCHOLESTEROLEMIA AND CELLULAR HYPERPROLIFERATIVE DISORDERS. | UNIV TEXAS (US) | 1993-03-03 | — | — | EP | claimed |
| WO-1991018593-A1 | FORMULA AND METHOD FOR THE PREVENTION AND TREATMENT OF HYPERCHOLESTEROLEMIA AND CELLULAR HYPERPROLIFERATIVE DISORDERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-12-12 | — | — | WO | claimed |
| EP-0164908-B1 | PROCESS FOR PREPARATION OF COMPOSITIONS FOR MODIFYING PLANT GROWTH; COMPOSITION FOR PLANT GROWTH MODIFICATION: AND METHOD FOR THE USE THEREOF | ACTAGRO, INC. (US) | 1989-09-13 | — | — | EP | claimed |